Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 415
5
Diseases
4
Unique genes
0.312
Avg. similarity score
Bestrophinopathy
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Bestrophinopathy
Vitreoretinochoroidopathy
hemochromatosis type 5
neurodegeneration with brain iron accumulation 9
BEST1-related dominant retinopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Bestrophinopathy | 4 | 4 | 4 |
| Vitreoretinochoroidopathy | 4 | 4 | 2 |
| hemochromatosis type 5 | 3 | 3 | 1 |
| neurodegeneration with brain iron accumulation 9 | 3 | 3 | 1 |
| BEST1-related dominant retinopathy | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| FTH1 | 4 / 5 | Bestrophinopathy, hemochromatosis type 5, neurodegeneration with brain iron accumulation 9, Vitreoretinochoroidopathy |
| BEST1 | 3 / 5 | BEST1-related dominant retinopathy, Bestrophinopathy, Vitreoretinochoroidopathy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Iron uptake and transport | Reactome | 1 / 28 | 107× | 9.29e-3 | 6.56e-2 |
| Ferroptosis | KEGG | 1 / 42 | 71.5× | 1.39e-2 | 8.32e-2 |
| Porphyrin metabolism | KEGG | 1 / 46 | 65.3× | 1.52e-2 | 8.78e-2 |
| Golgi Associated Vesicle Biogenesis | Reactome | 1 / 56 | 53.6× | 1.85e-2 | 9.85e-2 |
| Mineral absorption | KEGG | 1 / 61 | 49.2× | 2.02e-2 | 1.03e-1 |
| Stimuli-sensing channels | Reactome | 1 / 79 | 38.0× | 2.61e-2 | 1.19e-1 |
| Hippo signaling pathway | KEGG | 1 / 157 | 19.1× | 5.13e-2 | 1.74e-1 |
| Necroptosis | KEGG | 1 / 159 | 18.9× | 5.19e-2 | 1.75e-1 |
| Neutrophil degranulation | Reactome | 1 / 480 | 6.3× | 1.51e-1 | 3.10e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| detection of light stimulus involved in visual perception | GO:0050908 | 3 / 24 | 584× | 7.44e-9 | 1.32e-6 ✓ sig. |
| photoreceptor cell outer segment organization | GO:0035845 | 2 / 15 | 623× | 3.61e-6 | 2.31e-4 ✓ sig. |
| visual perception | GO:0007601 | 3 / 215 | 65.2× | 5.96e-6 | 3.45e-4 ✓ sig. |
| retina development in camera-type eye | GO:0060041 | 2 / 85 | 110× | 1.22e-4 | 3.51e-3 ✓ sig. |
| response to low light intensity stimulus | GO:0009645 | 1 / 1 | 4,672× | 2.14e-4 | 5.28e-3 ✓ sig. |
| gamma-aminobutyric acid secretion, neurotransmission | GO:0061534 | 1 / 2 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| post-embryonic retina morphogenesis in camera-type eye | GO:0060060 | 1 / 2 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| establishment of bipolar cell polarity involved in cell morphogenesis | GO:0061159 | 1 / 2 | 2,336× | 4.28e-4 | 8.59e-3 ✓ sig. |
| transepithelial chloride transport | GO:0030321 | 1 / 9 | 519× | 1.93e-3 | 2.20e-2 ✓ sig. |
| glutamate secretion | GO:0014047 | 1 / 11 | 425× | 2.35e-3 | 2.48e-2 ✓ sig. |
| negative regulation of ferroptosis | GO:0110076 | 1 / 14 | 334× | 2.99e-3 | 2.82e-2 ✓ sig. |
| retina morphogenesis in camera-type eye | GO:0060042 | 1 / 14 | 334× | 2.99e-3 | 2.82e-2 ✓ sig. |
| protein heterooligomerization | GO:0051291 | 1 / 15 | 311× | 3.21e-3 | 2.91e-2 ✓ sig. |
| cellular response to light stimulus | GO:0071482 | 1 / 16 | 292× | 3.42e-3 | 3.03e-2 ✓ sig. |
| plasma membrane organization | GO:0007009 | 1 / 21 | 222× | 4.49e-3 | 3.47e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Bestrophinopathy | Vitreoretinochoroidopathy | 0.400 | 2 | 5.06e-8 | 3.92e-7 ✓ sig. |
| hemochromatosis type 5 | neurodegeneration with brain iron accumulation 9 | 0.500 | 1 | 6.49e-5 | 2.34e-4 ✓ sig. |
| BEST1-related dominant retinopathy | Vitreoretinochoroidopathy | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| hemochromatosis type 5 | Vitreoretinochoroidopathy | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| neurodegeneration with brain iron accumulation 9 | Vitreoretinochoroidopathy | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| BEST1-related dominant retinopathy | Bestrophinopathy | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Bestrophinopathy | hemochromatosis type 5 | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Bestrophinopathy | neurodegeneration with brain iron accumulation 9 | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |